Modulation of Lymphocyte Function for Cancer Therapy: A Phase II Trial of Tremelimumab in Advanced Gastric and Esophageal Adenocarcinoma

被引:0
|
作者
Ralph, Christy [1 ,2 ]
Elkord, Eyad [1 ]
Thistlethwaite, Fiona C. [1 ]
Burt, Debbie J. [1 ]
O'Dwyer, Jackie [1 ]
Stern, Peter L. [2 ]
Hawkins, Robert F.
机构
[1] Christie NHS Fdn Trust, Paterson Inst Canc Res, Manchester, Lancs, England
[2] Univ Manchester, Paterson Inst Canc Res, Manchester, Lancs, England
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:960 / 961
页数:2
相关论文
共 50 条
  • [31] A Phase II Trial of Adjuvant Durvalumab Following Trimodality Therapy for Locally Advanced Esophageal and Gastroesophageal Junction Adenocarcinoma: A Big Ten Cancer Research Consortium Study
    Mamdani, Hirva
    Schneider, Bryan
    Perkins, Susan M.
    Burney, Heather N.
    Kasi, Pashtoon Murtaza
    Abushahin, Laith, I
    Birdas, Thomas
    Kesler, Kenneth
    Watkins, Tracy M.
    Badve, Sunil S.
    Radovich, Milan
    Jalal, Shadia, I
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [32] A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared with Chemoradiotherapy in Locally Advanced Gastric Adenocarcinoma
    Wang, X.
    Jin, J.
    Zhao, D. B.
    Chi, Y. H. B. L.
    Yang, L.
    Jiang, L.
    Dou, L. Z.
    Tang, Y.
    Li, N.
    Liu, W., Jr.
    Tian, Y. T.
    Zhao, H.
    Che, X.
    Bai, X. F.
    Lu, N.
    Hua, R.
    Fang, H.
    Wang, S. L.
    Song, Y. W.
    Liu, Y.
    Li, Y. X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S29 - S30
  • [33] A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiation Therapy in Locally Advanced Gastroesophageal and Gastric Adenocarcinoma: Preliminary Results
    Wang, X.
    Zhao, D. B.
    Jin, J.
    Chi, Y.
    Yang, L.
    Tang, Y.
    Che, X.
    Zhao, H.
    Jiang, L. M.
    Ren, H.
    Liu, W., Jr.
    Li, N.
    Li, Y. X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S32 - S32
  • [34] Phase II trial of bevacizumab, irinotecan, cisplatin, and radiation as preoperative therapy in esophageal adenocarcinoma.
    Ilson, David
    Goodman, Karyn A.
    Janjigian, Yelena Yuriy
    Shah, Manish A.
    Kelsen, David Paul
    Rizk, Nabil P.
    Rusch, Valerie W.
    Wu, Abraham Jing-Ching
    Campbell, Jenny
    Capanu, Marinela
    Bains, Manjit S.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [35] PHASE-II TRIAL OF GEMCITABINE IN PATIENTS WITH ADVANCED GASTRIC-CANCER
    CHRISTMAN, K
    KELSEN, D
    SALTZ, L
    TARASSOFF, PG
    CANCER, 1994, 73 (01) : 5 - 7
  • [36] Oxaliplatin and Irinotecan in advanced gastric cancer.: A multicenter phase II trial
    Woell, E.
    Eisterer, W.
    Hilbe, W.
    Kuehr, T.
    Gattringer, K.
    Greil, R.
    Zabernigg, A.
    Baldinger, C.
    Thaler, J.
    EJC SUPPLEMENTS, 2005, 3 (02): : 213 - 213
  • [37] A phase I/II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer
    Kyoung Ha Kim
    Young Suk Park
    Myung Hee Chang
    Hyo Song Kim
    Hyun Jung Jun
    Jieun Uhm
    Seong Yoon Yi
    Do Hyoung Lim
    Sang Hoon Ji
    Min Jae Park
    Jeeyun Lee
    Se Hoon Park
    Joon Oh Park
    Ho Yeong Lim
    Won Ki Kang
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 347 - 353
  • [38] A phase II trial of weekly fractionated irinotecan and cisplatin for advanced gastric cancer
    Hei-Cheul Jeung
    Sun Young Rha
    Sung Hoon Noh
    Jae Kyung Roh
    Hyun Cheol Chung
    Cancer Chemotherapy and Pharmacology, 2007, 59 : 313 - 320
  • [39] A phase II trial of weekly fractionated irinotecan and cisplatin for advanced gastric cancer
    Jeung, Hei-Cheul
    Rha, Sun Young
    Noh, Sung Hoon
    Roh, Jae Kyung
    Chung, Hyun Cheol
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (03) : 313 - 320
  • [40] A phase I/II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer
    Kim, Kyoung Ha
    Park, Young Suk
    Chang, Myung Hee
    Kim, Hyo Song
    Jun, Hyun Jung
    Uhm, Jieun
    Yi, Seong Yoon
    Lim, Do Hyoung
    Ji, Sang Hoon
    Park, Min Jae
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Lim, Ho Yeong
    Kang, Won Ki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (02) : 347 - 353